Hunter Gillies Aerovate Therapeutics, Inc. (AVTE) insider trading activity

Hunter Gillies is CHIEF MEDICAL OFFICER of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 5,602 shares of AVTE, which is worth approximately $14,957. The most recent transaction as insider was on Dec 13, 2023, when has been sold 2,103 shares (Common Stock) at a price of $1.74 per share, resulting in proceeds of $3,659. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.6K

0% 3M change

72.32% 12M change

Total Value Held $14,957

Hunter Gillies Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 13 2023	BUY Exercise of conversion of derivative security	$3,659 $1.74 p/Share	2,103 Added 28.2%	5,354 Common Stock
May 19 2023	SELL Open market or private sale	$1,267 $19.5 p/Share	65 Reduced 1.96%	3,251 Common Stock
May 19 2023	BUY Exercise of conversion of derivative security	$113 $1.74 p/Share	65 Added 1.92%	3,316 Common Stock
May 17 2023	SELL Open market or private sale	$21,353 $19.59 p/Share	1,090 Reduced 25.11%	3,251 Common Stock
May 17 2023	BUY Exercise of conversion of derivative security	$1,896 $1.74 p/Share	1,090 Added 20.07%	4,341 Common Stock
Apr 21 2023	SELL Open market or private sale	$78,000 $19.5 p/Share	4,000 Reduced 67.11%	1,960 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	$6,960 $1.74 p/Share	4,000 Added 40.16%	5,960 Common Stock

Hunter Gillies

CHIEF MEDICAL OFFICER

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Value

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE

Account